Case Reports
Intravitreal bevacizumab injection for chronic central serous chorioretinopathy
Affiliations
- PMID: 20819558
Item in Clipboard
Case Reports
Intravitreal bevacizumab injection for chronic central serous chorioretinopathy
Chin Med J (Engl).
.
No abstract available
Similar articles
-
Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy.Eye (Lond). 2009 Feb;23(2):488-9. doi: 10.1038/eye.2008.55. Epub 2008 Mar 14. Eye (Lond). 2009. PMID: 18344956 No abstract available.
-
Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy.Acta Ophthalmol. 2011 May;89(3):e293-4. doi: 10.1111/j.1755-3768.2009.01835.x. Acta Ophthalmol. 2011. PMID: 20346078 No abstract available.
-
[Recurrent and chronic central serous chorioretinopathy. Retina thickness evaluation one month after intravitreal bevacizumab injection].Arch Soc Esp Oftalmol. 2011 Dec;86(12):407-11. doi: 10.1016/j.oftal.2011.05.021. Epub 2011 Oct 11. Arch Soc Esp Oftalmol. 2011. PMID: 22117740 Clinical Trial. Spanish.
-
[Central serous chorioretinopathy--uptodate treatment options].Vestn Oftalmol. 2012 Nov-Dec;128(6):62-4. Vestn Oftalmol. 2012. PMID: 23367766 Review. Russian.
-
Current concepts in managing central serous chorioretinopathy.Ophthalmic Surg Lasers Imaging Retina. 2014 Jan-Feb;45(1):9-13. doi: 10.3928/23258160-20131220-01. Ophthalmic Surg Lasers Imaging Retina. 2014. PMID: 24392907 Review. No abstract available.
Cited by
-
Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage.Chin Med J (Engl). 2015 Aug 5;128(15):2078-83. doi: 10.4103/0366-6999.161371. Chin Med J (Engl). 2015. PMID: 26228222 Free PMC article. Clinical Trial.
-
Central serous chorioretinopathy: update on pathophysiology and treatment.Surv Ophthalmol. 2013 Mar-Apr;58(2):103-26. doi: 10.1016/j.survophthal.2012.07.004. Surv Ophthalmol. 2013. PMID: 23410821 Free PMC article. Review.
-
Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients.Eye (Lond). 2015 Jun;29(6):732-40; quiz 741. doi: 10.1038/eye.2015.58. Epub 2015 May 8. Eye (Lond). 2015. PMID: 25952951 Free PMC article.
-
Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review.Eye (Lond). 2013 Dec;27(12):1339-46. doi: 10.1038/eye.2013.236. Epub 2013 Nov 8. Eye (Lond). 2013. PMID: 24202051 Free PMC article. Review.
-
Interventions for central serous chorioretinopathy: a network meta-analysis.Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3. Cochrane Database Syst Rev. 2025. PMID: 40522203
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
